Project 1: Genetic Analysis

项目1:遗传分析

基本信息

  • 批准号:
    10555696
  • 负责人:
  • 金额:
    $ 58.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-07-01 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

SUMMARY Alzheimer’s disease (AD) is heritable with a large proportion of phenotypic variability explained by genetic components. Identifying these factors, particularly those that are modifiable in plasma biomarkers, could lead to effective AD treatments and risk reduction strategies. Multi-ethnic studies showed that population differences in genetic background can be leveraged to make novel discoveries that might require a sample sizes several orders of magnitude larger than existing subject collections to achieve similar success within a single sub- population. Genome-wide association study (GWAS) for AD has been focused on mostly Europeans ancestry, especially lacking a large-scale GWAS in Asian Americans and Canadians. Heritability of AD is currently unknown in Asians, and AD polygenic risk score applicable to Asians has not been established. The overarching goal of the Project 1 is to uncover risk and protective variants for AD and plasma biomarkers in the Asian Cohort for AD (ACAD). We propose a comprehensive approach in three specific aims. For Aim 1, we will identify risk and protective variants for AD in ACAD participants and compare the results to Asian and non-Asian populations. In collaboration with Data Management and Analysis Core (Core D), this is the first major AD genetics study of Asians in the US and Canada and will compare results with existing East Asians and multi-ethnic datasets obtained from the Alzheimer Disease Genetic Consortium (ADGC). For Aim 2, we will understand genetic architecture for plasma AD biomarkers in ACAD participants. We will identify quantitative trait loci (QTL) for plasma AD related biomarkers including Aβ peptides, total tau (t-tau), phosphorylated-tau (p-tau 181), and neurofilament light chain (NfL) in collaboration with Core D, Biosampe Core, and Project 2. For Aim 3, we will determine heritability of AD and establish AD polygenic risk score (ADPRS) in ACAD participants. Our study will provide insights on Asian ancestry specific (ASAC and/or Asians) and multi-ethnic targets in AD therapeutics. We anticipate that results from this study will facilitate potential novel, population-specific therapeutic targets for AD for treating and preventing AD. The results from this proposal will provide the important synergy to further investigate gene-environment interactions in Project 2.
总结 阿尔茨海默病(AD)是一种可遗传的疾病,其表型变异的很大一部分可以通过遗传因素来解释。 件.识别这些因素,特别是那些在血浆生物标志物中可改变的因素,可能会导致 有效的AD治疗和风险降低策略。多种族研究表明, 在遗传学背景中,可以利用新的发现,这可能需要几个样本大小, 数量级大于现有的主题集合,以实现类似的成功,在一个单一的子, 人口AD的全基因组关联研究(GWAS)主要集中在欧洲血统, 尤其是在亚裔美国人和加拿大人中缺乏大规模的GWAS。AD的遗传性目前 在亚洲人中未知,适用于亚洲人的AD多基因风险评分尚未建立。的 项目1的首要目标是揭示AD和血浆的风险和保护性变体 亚洲AD队列(ACAD)中的生物标志物。我们建议在三个具体方面采取综合办法 目标。对于目标1,我们将确定ACAD参与者中AD的风险和保护性变体,并比较 亚洲人和非亚洲人。数据管理和分析核心(Data Management and Analysis Core) D),这是美国和加拿大首次对亚洲人进行的主要AD遗传学研究,并将结果与 现有的东亚人和从阿尔茨海默病遗传联盟获得的多种族数据集 (ADGC)。对于目标2,我们将了解ACAD参与者中血浆AD生物标志物的遗传结构。 我们将鉴定血浆AD相关生物标志物的数量性状基因座(QTL),包括Aβ肽、总tau蛋白、 (t-tau)、磷酸化tau(p-tau 181)和神经丝轻链(NfL), Biosampe Core和项目2。对于目标3,我们将确定AD的遗传度并建立AD多基因风险 ACAD参与者的ADPRS评分。我们的研究将提供关于亚洲血统特定(ASAC和/或 亚洲人)和AD治疗中的多种族靶点。我们预计,这项研究的结果将有助于 用于治疗和预防AD的潜在的新的、人群特异性的AD治疗靶点。的结果 这一建议将为进一步研究基因与环境的相互作用提供重要的协同作用, 2.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gyungah Jun其他文献

Gyungah Jun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gyungah Jun', 18)}}的其他基金

Core D: Data Management and Analysis Core
核心D:数据管理与分析核心
  • 批准号:
    10555693
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:

相似海外基金

Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry
与非洲血统相关的多发性骨髓瘤肿瘤生物学差异
  • 批准号:
    10656009
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:
Identifying placental injury pathways in women of African ancestry with severe preeclampsia
确定患有严重先兆子痫的非洲血统女性的胎盘损伤途径
  • 批准号:
    10742342
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:
Community to Molecular Approaches in Early Screening and Diagnosis to Promote Equitable Outcomes Through the Continuum of Care in Cancer Among Populations of African Ancestry
社区采用分子方法进行早期筛查和诊断,通过对非洲裔人群癌症的持续护理来促进公平结果
  • 批准号:
    10754038
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:
Genomics of Renal Cancer in Patients of African Ancestry
非洲血统患者肾癌的基因组学
  • 批准号:
    10648882
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:
Improving Genetic Diagnosis for African Ancestry Populations
改善非洲血统人群的基因诊断
  • 批准号:
    10736833
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:
Genetics of PTSD in African Ancestry Populations: Enhancing discovery by addressing inequality
非洲血统人群 PTSD 的遗传学:通过解决不平等问题加强发现
  • 批准号:
    10750547
  • 财政年份:
    2023
  • 资助金额:
    $ 58.66万
  • 项目类别:
Microfluidic Droplet Organoids to Decipher the Tumor Heterogeneity in CRC of African Ancestry
微流控液滴类器官破译非洲血统结直肠癌肿瘤异质性
  • 批准号:
    10355977
  • 财政年份:
    2022
  • 资助金额:
    $ 58.66万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
  • 批准号:
    10772527
  • 财政年份:
    2022
  • 资助金额:
    $ 58.66万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测
  • 批准号:
    10445739
  • 财政年份:
    2022
  • 资助金额:
    $ 58.66万
  • 项目类别:
Understanding the contribution of genotype-by-lifestyle interactions to cardiometabolic risk in individuals of east African ancestry
了解基因型与生活方式的相互作用对东非血统个体心脏代谢风险的影响
  • 批准号:
    10537570
  • 财政年份:
    2022
  • 资助金额:
    $ 58.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了